To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Hour Detroit’s 2023 Top Docs List is out; over 30 physicians from the Barbara Ann Karmanos Cancer Institute are listed. Each year, Hour Detroit Magazine puts out an online peer-to-peer review survey conducted by Professional Research Services (PRS) to determine the top physicians in southeastern Michigan. Participating physicians in Wayne, Oakland, Macomb, Washtenaw, and Livingston Counties nominate the best doctors in each field. This year’s list also includes a feature with George Yo...
The Barbara Ann Karmanos Institute’s third annual Prostate Cancer Awareness Night with the Detroit Tigers and McLaren Health Care, the official healthcare system of the Tigers, united hundreds of prostate cancer survivors and their loved ones from near and far. Cheering on the Detroit Tigers as they competed against the Kansas City Royals on June 20, 2023, Comerica Park was decorated with a blue theme, and fans raised blue Tigers foam fingers to promote prostate cancer awareness and support. “In prostat...
Michael Cher, M.D. , urologic oncologist, member of the Genitourinary Oncology Multidisciplinary Team at Barbara Ann Karmanos Cancer Institute and chair of the Wayne State University Department of Urology, co-authored a study outlining the results of a bladder cancer clinical trial recently published in the new journal, NEJM Evidence. ”IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer,” focused on a new treatment option that could effectively treat patients with non–muscle-in...